Border Lines: BEIJING - Ruder Finn launches Aventis in China

Life sciences giant Aventis, formed by recently merged companies Hoescht and Rhone-Poulenc, has hired Ruder Finn to launch its pharmaceutical arm in China. Ruder Finn will run a four-month positioning campaign for Aventis Pharma while the new company awaits a business licence in China. The brief includes development of PR collaterals and launch events in Beijing and Shanghai. Aventis Pharma researches and develops therapies for diseases including diabetes and cancer. The account will be led by Ruder Finn healthcare senior account manager James Liu in Shanghai.

Life sciences giant Aventis, formed by recently merged companies

Hoescht and Rhone-Poulenc, has hired Ruder Finn to launch its

pharmaceutical arm in China. Ruder Finn will run a four-month

positioning campaign for Aventis Pharma while the new company awaits a

business licence in China. The brief includes development of PR

collaterals and launch events in Beijing and Shanghai. Aventis Pharma

researches and develops therapies for diseases including diabetes and

cancer. The account will be led by Ruder Finn healthcare senior account

manager James Liu in Shanghai.



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.